  |
Anjin Pharmaceuticals renamed Lucky Pharmaceuticals. |
  |
Interferon-gamma product sold as Intermax-gamma. |
|
  |
World first 4th-generation cephalosporin antibiotic completed; technology exported to Glaxo (now GSK) of the UK. |
  |
Korean government GMP designation granted to pharmaceutical plant. |
  |
Interferon-gamma given IR52 Chang Young-sil Award. |
  |
Lucky Pharmaceuticals merged with Lucky Ltd. |
|
  |
US$4M worth of Intermax-gamma exported to Thailand. |
  |
Korea first in-vitro diagnostics for hepatitis (LUCKY-HCD™) commercialized. |
  |
Intermax-alpha, Intermax-gamma and hepatitis B vaccine exported to Egypt. |
|
  |
Korea first human growth hormone (EUTROPIN™) put on market. |
  |
Procymidone pesticide commercialized for horticultural use. |
  |
EUTROPIN™ human growth hormone given IR52 Chang Young-sil Award. |
  |
EUVAX B™ hepatitis B vaccine exported to Singapore. |
|
  |
Agrochemical Business Division launched. |
  |
Procymidone pesticide given IR52 Chang Young-sil Award. |
  |
In-vitro diagnostics for hepatitis C (LG-HCD) completed. |
  |
BOOSTIN recombinant BST commercialized. |
  |
Genetically engineered products (EUTROPIN™, Intermax-alpha, EUVAX B™) introduced to S. American market; first phase of LG Chemical Research Park completed. |
|
  |
Company renamed LG Chemical; new CI launched. |
  |
Contract signed for agrochemical production joint venture in China. |
  |
Leukocyte production stimulant (LEUCOGEN™) commercialized. |
  |
First phase of Iksan pharmaceutical plant competed. |
  |
BOOSTIN rBST exported to Egypt. |
  |
BOOSTIN rBST given IR52 Chang Young-sil Award. |
  |
Iksan plant granted KGMP designation for 9 major pharmaceutical products. |
  |
Production technology for hypertension treatment received from Nippon Chemipha. |
|
  |
R&D operation reorganized into Biotech I and Biotech II. |
  |
Aggregate exports of rBST topped US$5M. |
  |
Leukocyte production stimulant (LEUCOGEN™) given IR52 Chang Young-sil Award. |
  |
Second phase of LG Chemical Research Park completed. |
  |
Agreement for joint research on cardio-circulatory disease signed with TBC of the US. |
|
  |
Agrochemical R&D Center opened (independent of Specialty Chemical R&D Center). |
|
New-formula herbicide (PYANCOR commercialized. |
  |
LGBMI established in US as bioengineering research facility. |
  |
DAMA, Korea first cephalosporin antibiotic intermediate, commercialized. |
  |
Quinolone antibiotic technology exported to Smith-Kline Beecham Pharmaceuticals of the UK. |
  |
EUVAX B™ hepatitis B vaccine exported for 3rd world immunization program. |
  |
DAMA cephalosporin antibiotic intermediate given IR52 Chang Young-sil Award; production technology for oral anticoagulant medication exported to Warner Lambert of the US. |
  |
Strategic marketing alliance for 6 genetically engineered drugs signed with Merck of Germany. |
  |
Herbicide (PYANCOR given IR52 Chang Young-sil Award of the Year (Presidential Prize). |
|
  |
Sodium hyaluronate for ophthalmic surgery (HYAL 2000® Injection) commercialized. |
  |
Company designated fficial chemical substance toxicity testing institution. |
  |
PYANCOR herbicide and hyaluronic acid (hyaluronsan) arthritis treatment given KT Mark and awarded LG R&D Prize. |
  |
LG Chemical Research Park Quniolone Team won Prime Minister Prize at Patent Technology Awards; hyaluronan arthritis treatment commercialized; BST marketing agreement concluded with Shering-Plough of the US; ACCENT™ veterinarian-use antibiotic commercialized. |
  |
Quinolone antibiotic completed Phase II Clinical Trial overseas. |
  |
Choson ilbo selects EUTROPIN™ as one of ROK 50 top scientific achievements. |
  |
EUVECTIN™ parasiticide for cattle commercialized. |
  |
Deltamethrin agrochemical base chemical given IR52 Chang Young-sil Award. |
|
  |
Agreement for joint research of antivirus compounds signed with Smith-Beecham of the UK. |
  |
Development of GUARDIAN an environmentally benign fungicide, completed. |
  |
ESPOGEN™ anemia treatment commercialized. |
  |
GUARDIAN fungicide given Central Patented Technology Prize; strategic agreement for overseas marketing of PYANCOR herbicide signed with Rohm & Haas Company; LG LARVANIL larvacide for animal feed commercialized. |
  |
Permethrin insecticide registered at US Environmental Protection Agency. |
  |
Quinolone antibiotic completed Phase III Clinical Trial overseas; application submitted for FDA approval. |